Reichenbach, Gabi <br/><br/>
PPARα agonist Wy14643 suppresses cathepsin B in human endothelial cells via transcriptional, post-transcriptional and post-translational mechanisms.  [electronic resource] 

 -  Angiogenesis  Jan 2013 
 - 223-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7209 
<br/><br/><label>Standard No.: </label>10.1007/s10456-012-9314-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alternative Splicing--drug effects<br/>Base Pairing--genetics<br/>Blotting, Western<br/>Cathepsin B--genetics<br/>Down-Regulation--drug effects<br/>E-Box Elements--genetics<br/>Exons--genetics<br/>Half-Life<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>PPAR alpha--agonists<br/>Promoter Regions, Genetic--genetics<br/>Protein Binding--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Pyrimidines--pharmacology<br/>RNA, Messenger--genetics<br/>Subcellular Fractions--drug effects<br/>Transcription, Genetic--drug effects<br/>Upstream Stimulatory Factors--metabolism